The Federal Trade Commission (FTC) and the states of New York, California, Illinois, North Carolina, Ohio, Pennsylvania, and Virginia are set to recoup up to $40 million in relief for victims of an illegal scheme masterminded by Martin Shkreli.
The FTC said in a press release Tuesday that the government agency, alongside several states, accuses Vyera Pharmaceuticals and Shkreli, its former CEO, as well as his associate Kevin Mulleady, and Vyera’s parent company Phoenixus AG of fleecing patients dependent on the life-saving drug Daraprim through the illegal scheme.
